Kurz gefasst
Fachartikel in der Zeitschrift PUBLISSO, erschienen am 01.01.2026. Verfasst von Ernst Hallier und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has re‐evaluated the BLW (“Biologischer Leitwert”) for methyl bromide, using bromide in serum/plasma to characterise the internal exposure. The critical effect of methyl bromide is a high acute and chronic neurotoxicity. It can pass through the skin so that biological monitoring is highly recommended. On the basis of results of a human study the occurrence of abnormal findings in the EEG is comparable for unexposed persons and persons with exposure to methyl bromide in concentrations below 12 mg bromide/l plasma. Thus the BLW of 12 mg bromide/l plasma or serum was confirmed. The sampling time for long‐term exposure is at the end of exposure/shift after several previous shifts. The evaluation of an EKA for methyl bromide in the air and S‐methylcysteine‐albumin adducts in blood is not possible as there is insufficient data available.
Schlagwörter
Zitieren
APA
Hallier, E., Müller, M. M., Drexler, H. G., Hartwig, A., & Commission, M. (2026). Addendum to Methyl bromide. PUBLISSO. https://doi.org/10.34865/bb7483e2217_w
Vancouver
Hallier E, Müller MM, Drexler HG, Hartwig A, Commission M. Addendum to Methyl bromide. PUBLISSO. 2026. doi:10.34865/bb7483e2217_w
BibTeX
@article{Hallier2026,
author = {Hallier, Ernst and Müller, Michael M. and Drexler, Hans Günter and Hartwig, Andrea and Commission, MAK},
title = {Addendum to Methyl bromide},
journal = {PUBLISSO},
year = {2026},
doi = {10.34865/bb7483e2217_w}
}
EUVIMED